Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-11868-9, published online 08 November 2017
The original version of this Article contained an error in the order of author names, which were incorrectly given as ‘Yang Zhang, Yinfang Wu, Hui Qi, Hongwei Gong, Yan Zhang, Enquan Xu, Song Li, Dalong Ma, Junhai Xiao, Ying Wang, Wen Li & Huahao Shen’.
In addition, the version of this Article previously published omitted Junhai Xiao as an equally contributing author.
These errors have now been corrected in the HTML and PDF versions of this Article.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The original article can be found online at https://doi.org/10.1038/s41598-017-11868-9.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, Y., Wu, Y., Qi, H. et al. Publisher Correction: A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma. Sci Rep 8, 6859 (2018). https://doi.org/10.1038/s41598-018-23185-w
Published:
DOI: https://doi.org/10.1038/s41598-018-23185-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
